(Q37004503)

17 August 2017

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults (English)

1 reference

17 August 2017

0 references

0 references

S Migasena

1

1 reference

17 August 2017

P Pitisuttitham

2

1 reference

17 August 2017

B Prayurahong

3

1 reference

17 August 2017

P Suntharasamai

4

1 reference

17 August 2017

W Supanaranond

5

1 reference

17 August 2017

V Desakorn

6

1 reference

17 August 2017

U Vongsthongsri

7

1 reference

17 August 2017

B Tall

8

1 reference

17 August 2017

J Ketley

9

1 reference

17 August 2017

G Losonsky

10

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 1989

1 reference

17 August 2017

Infection and Immunity

1 reference

17 August 2017

57

1 reference

17 August 2017

11

1 reference

17 August 2017

3261-3264

1 reference

Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Field trial of oral cholera vaccines in Bangladesh

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Field Trial of Oral Cholera Vaccines in Bangladesh: Results of One Year of Follow-Up

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259791

Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2807523

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE CYTOTOXIN

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2807523

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2807523

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/IAI.57.11.3261-3264.1989

0 references

1 reference

17 August 2017

PubMed publication ID

2807523

1 reference